Literature DB >> 35466309

Management of Fistulas in Patients With Crohn's Disease.

Amy L Lightner1.   

Abstract

Entities:  

Year:  2021        PMID： 35466309      PMCID： PMC9021165     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.

Authors:  Allan B Dietz; Eric J Dozois; Joel G Fletcher; Greg W Butler; Darcie Radel; Amy L Lightner; Maneesh Dave; Jessica Friton; Asha Nair; Emily T Camilleri; Amel Dudakovic; Andre J van Wijnen; William A Faubion
Journal:  Gastroenterology       Date:  2017-04-09       Impact factor: 22.682

Review 2.  Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: What We Have Accomplished and What We Still Need to Do.

Authors:  Amy L Lightner; William A Faubion
Journal:  J Crohns Colitis       Date:  2017-10-01       Impact factor: 9.071

Review 3.  A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions.

Authors:  Amy L Lightner; Zhen Wang; Abba C Zubair; Eric J Dozois
Journal:  Dis Colon Rectum       Date:  2018-05       Impact factor: 4.585

Review 4.  Cell-based Therapy for Perianal Fistulising Crohn's Disease.

Authors:  Paulo Gustavo Kotze; Antonino Spinelli; Amy Lee Lightner
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

Review 5.  Modern management of perianal fistulas in Crohn's disease: future directions.

Authors:  Paulo Gustavo Kotze; Bo Shen; Amy Lightner; Takayuki Yamamoto; Antonino Spinelli; Subrata Ghosh; Remo Panaccione
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

Review 6.  Mesenchymal Stem Cells for Perianal Crohn's Disease.

Authors:  Michele Carvello; Amy Lightner; Takayuki Yamamoto; Paulo Gustavo Kotze; Antonino Spinelli
Journal:  Cells       Date:  2019-07-23       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.